The largest purchase of all time was on 2019-05-09 and amounted to 5000000 shares of Trevi Therapeutics, Inc. for $50M.
The largest sale of all time was on 2020-04-03 and amounted to 1128 shares of Trevi Therapeutics, Inc. for $3,000.
No biography is available at this moment.
| 2023-07-17 | Savara Inc. SVRA | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.17% | ||
| 2023-07-05 | Black Diamond Therapeutics, Inc. BDTX | director | 1M 2.8199% | $5.00 | $5M | -26.34% | ||
| 2021-10-18 | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 1.85M 11.1305% | $1.62 | $3M | +63.35% | ||
| 2021-06-28 | Monte Rosa Therapeutics, Inc. GLUE | 1.05M 20.5778% | $19.00 | $19.95M | -7.95% | |||
| 2021-03-16 | Marker Therapeutics, Inc. MRKR | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.3% | ||
| 2020-12-04 | Regulus Therapeutics Inc. RGLS | 10 percent owner | 4.4M 7.578% | $0.62 | $2.74M | +22.37% | ||
| 2020-04-03 | Sale | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 1,128 0.0062% | $2.66 | $3,000 | +19.07% | |
| 2020-02-03 | Black Diamond Therapeutics, Inc. BDTX | director | 1.6M 3.3756% | $19.00 | $30.4M | -15.11% | ||
| 2020-01-24 | Adaptimmune Therapeutics plc ADAP | director | 7.5M 1.0346% | $0.67 | $5M | +34.69% | ||
| 2019-07-22 | Mirum Pharmaceuticals, Inc. MIRM | 10 percent owner | 900,000 5.3814% | $15.00 | $13.5M | +5.09% | ||
| 2019-05-09 | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 5M 34.6117% | $10.00 | $50M | -42.9% | ||
| 2019-05-07 | Regulus Therapeutics Inc. RGLS | 10 percent owner | 1.14M 6.1239% | $1.08 | $1.23M | -40% | ||
| 2018-09-07 | Adaptimmune Therapeutics plc ADAP | director | 24M 3.8977% | $1.67 | $40M | -57.66% |